By Dr John James Moore

Journal articles

Morrissey CO; Chen SC-A; Sorrell TC; Milliken S; Bardy PG; Bradstock KF; Szer J; Halliday CL; Gilroy NM; Moore J; Schwarer AP; Guy S; Bajel A; Tramontana AR; Spelman T; Slavin MA, 2013, 'Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial', The Lancet Infectious Diseases, 13, pp. 519 - 528, http://dx.doi.org/10.1016/S1473-3099(13)70076-8

Moore J; Englert H; Furlong T; Poon T; Milliken S; Ma D, 2012, 'Auto-HSCT induces sustained responses in severe systemic sclerosis patients failing pulse cyclophosphamide', Bone Marrow Transplantation, 47, pp. 1486 - 1487, http://dx.doi.org/10.1038/bmt.2012.67

Snowden JA; Saccardi R; Allez M; Ardizzone S; Arnold R; Cervera R; Denton C; Hawkey C; Labopin M; Mancardi G; Martin R; Moore JJ; Passweg J; Peters C; Rabusin M; Rovira M; Van Laar JM; Farge D, 2012, 'Haematopoietic SCT in severe autoimmune diseases: Updated guidelines of the European group for blood and marrow transplantation', Bone Marrow Transplantation, 47, pp. 770 - 790, http://dx.doi.org/10.1038/bmt.2011.185

Mollee P; Tiley C; Cunningham I; Moore JJ; Prince M, 2012, 'A Phase II study of risk-adapted intravenous Melphalan in patiens with AL Amyloidosis', British Journal of Haematology, 157, pp. 766 - 769, http://dx.doi.org/10.1111/j.1365-2141.2012.09080.x

Iland ; Bradstock K; Supple S; Catalano A; Collins M; Hertzberg M; Browett P; Grigg A; Firkin F; Hugman A; Reynolds J; Di Iulio J; Tiley C; Taylor K; Filshie R; Seldon M; Taper J; Szer J; Moore JJ; Bashford J; Seymour JF, 2012, 'All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)', Blood, 120, pp. 1570 - 1580, http://dx.doi.org/10.1182/blood-2012-02-410746

Chih S; Mcdonald PS; Mccrohon JA; Ma DD; Moore JJ; Feneley MP; Law MG; Kovacic JC; Graham RM, 2012, 'Granulocyte colony stimulating factor in chronic angina to stimulate neovascularisation: A placebo-controlled crossover trial.', Heart, 98, pp. 282 - 290, http://dx.doi.org/10.1136/heartjnl-2011-300751

Snowden J; Saccardi R; Allez M; Ardizzone S; Arnold RH; Cervera R; Denton CP; Hawkey CJ; Labopin M; Mancardi GL; Martin RP; Moore JJ; Passweg J; Peters C; Rabusin M; Rovira M; Van Laar J; Farge D, 2012, 'Haematopoietic stem cell transplanation (HSCT) in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow transplatation (EBMT)', Bone Marrow Transplantation, 47, pp. 770 - 790

Carlin S; Khoo ML; Ma DD; Joseph JE, 2012, 'Notch Signalling Inhibits CD4 Expression during Initiation and Differentiation of Human T Cell Lineage', PLoS ONE, 7, pp. e45342, http://www.plosone.org/article/authors/info%3Adoi/10.1371/journal.pone.0045342

Moore JJ; Englert H; Furlong TJ, 2012, 'Stem cell transplant induces sustained responses in severe systemic sclerosis patients failing pulse cyclophosphamide', Bone Marrow Transplantation, 47, pp. 1486 - 1487

Mollee P; Tiley C; Cunningham I; Moore J; Prince M; Cannell P; Gibbons S; Tate J; Paul S; Gill DS, 2011, 'A Phase II Study of Risk-Adapted Intravenous Melphalan in Patients with AL Amyloidosis,', Blood, 118, pp. 3973 - 3973, http://dx.doi.org/10.1182/blood.v118.21.3973.3973

Nivison-Smith I; Dodds AJ; Dunkley H; Ma DD; Moore JJ; Simpson M; Szer J; Bradstock KF, 2011, 'Increased activity and improved outcome in unrelatred donor haemopoietic stem cell transplants for acute myeloid leukaemia in Australia, 1992-2005', Internal Medicine Journal, 41, pp. 27 - 34

Farge D; Labopin M; Tyndall A; Fassas A; Mancardi GL; Van Laar J; Ouyang J; Kozak T; Moore J; Kötter I; Chesnel V; Marmont A; Gratwohl A; Saccardi R, 2010, 'Autologous hematopoietic stem cell transplantation for autoimmune diseases: An observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases', Haematologica, 95, pp. 284 - 292, http://dx.doi.org/10.3324/haematol.2009.013458

Farge D; Labopin M; Tyndall A; Fassas A; Mancardi GL; Van Laar J; Moore JJ; Kozak T; Kotter I; Marmont A; Gratwohl A; Saccardi R, 2010, 'Autologous hematopoietic stem cell transplantation for autoimmune diseases', Haematologica, 95, pp. 284 - 292

Sasson SC; Smith S; Seddiki N; Zaunders J; Bryant AJ; Koelsch KK; Weatherall CJ; Munier CM; McGinley C; Yeung J; Mulligan S; Moore JJ; Cooper DA; Milliken ST; Kelleher AD, 2010, 'IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers', Cytokine, 50, pp. 58 - 68

Grimpen F; Yeung D; Joseph J; Fay K; Buckland M; Talaulikar D; Elijah J; Clarke AC; Pavli P; Moore J, 2009, 'Hepatosplenic T cell lymphoma, immunosuppressive agents and biologicals: what are the risks?', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A314 - A314, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200253&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Farge D; Labopin M; Tyndall A; Fassas A; Mancardi GL; Van Laar J; Ouyang J; Kozak T; Moore J; Kötter I; Chesnel V; Marmont A; Gratwohl A; Saccardi R, 2008, 'Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Autoimmune Diseases: 10 Years Experience from the European Group for Blood and Marrow Transplantation (EBMT) Working Party on Autoimmune Diseases', Blood, 112, pp. 164 - 164, http://dx.doi.org/10.1182/blood.v112.11.164.164

Potter V; Moore J, 2008, 'Randomised trials of graft versus host disease prophylaxis in haemopoietic stem cell transplantation', Reviews on Recent Clinical Trials, 3, pp. 130 - 138, http://dx.doi.org/10.2174/157488708784223790

Wong LY; Moore J; Hill D; Brenner P; Delprado W; Turner J; Taylor J; Campbell L; Greenfield JR, 2008, 'Custing's syndrome can precipitate diabetes but mask non-Hodgkin's lymphoma', Medical Journal of Australia, 188, pp. 262, http://dx.doi.org/10.5694/j.1326-5377.2008.tb01608.x

Farge-Bancel D; Labopin M; Tyndall A; Fassas A; Mancardi G-L; Van Laar J; Moore J; Kötter I; Chesnel V; Marmont A; Gratwohl A; Saccardi R, 2008, 'Autogreffe de cellules souches hématopoïétiques (ASH) au cours de la sclérodermie systémique : 10ans d’expérience du groupe de travail de l’EBMT-EULAR sur les maladies auto-immunes (MAI)', La Revue de Médecine Interne, 29, pp. S300 - S301, http://dx.doi.org/10.1016/j.revmed.2008.10.040

Englert H; Kirkham S; Moore JJ; Poon T; Katelaris C; McGill N; Schrieber L; Manolios N, 2008, 'Autologous stem cell transplantation in diffuse scleroderma: impact on hand structure and function', Internal Medicine Journal, 38, pp. 692 - 696, http://dx.doi.org/10.1111/j.1445-5994.2007.01593.x

Wong LY; Moore JJ; Hill D; Brenner PC; Delprado W; Turner J; Taylor J; Campbell L; Greenfield JR, 2008, 'Cushing`s syndrome can precipitate diabetes but mask non-Hodgkin`s lymphoma', Medical Journal of Australia, 188, pp. 262 - 262

Kovacic JC; Moore JJ; Herbert AD; Ma DD; Boehm M; Graham RM, 2008, 'Endothelial progenitor cells, angioblasts, and angiogenesis - Old terms reconsidered from a current perspective', Trends in Cardiovascular Medicine, 18, pp. 45 - 51

Kovacic JC; Macdonald PS; Feneley MP; Muller DW; Freund J; Dodds AJ; Milliken ST; Tao H; Itescu S; Moore JJ; Ma DD; Graham RM, 2008, 'Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD 133(+) cell infusion in patients with chronic refractory ischemic heart disease: The G-CSF in Angina patients with IHD to stimulate Neovascul', American Heart Journal, 156, pp. 954 - 963

Kovacic JC; Macdonald P; Feneley MP; Muller DW; Ma D; Tao H; Freund J; Milliken S; Dodds A; Moore J; Itescu S; Graham RM, 2007, 'Abstract 2669: The Use of Granulocyte-Colony Stimulating Factor in Angina Patients to Stimulate Neovascularization: the GAIN I study', Circulation, 116, http://dx.doi.org/10.1161/circ.116.suppl_16.ii_591-d

Moore JD; Baichi M; Toledo R; Sitrin M, 2007, 'Pseudomelanosis of jejunum and ileum', Gastrointestinal Endoscopy, 66, pp. 857 - 859, http://dx.doi.org/10.1016/j.gie.2007.01.030

Moore JJ; Nivison-Smith I; Goh K; Ma DD; Bradstock KF; Szer J; Durrant S; Schwarer AP; Bardy P; Herrmann RP; Dodds AJ, 2007, 'Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia', Biology of Blood and Marrow Transplantation, 13, pp. 601 - 607

Nivison-Smith I; Bradstock KF; Dodds AJ; Hawkins P; Ma DD; Moore JJ; Simpson JM; Szer J, 2007, 'Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004', Biology of Blood and Marrow Transplantation, 13, pp. 905 - 912

Kovacic JC; Ma DD; Tao H; Herbert AD; Moore JJ; Graham RM, 2007, 'Phenotypic characterization of CD133+cells suggests a potent hemangioblast population', Circulation Research, 101, pp. E55 - E56

Kovacic JC; Macdonald PS; Freund J; Rasko J; Allan RM; Fernandes VB; Ma DD; Moore JJ; Graham RM, 2007, 'Profound thrombocytopenia related to G-CSF', American Journal of Hematology, 82, pp. 229 - 230

Brown DA; Moore JJ; Johnen H; Smeets TJ; Bauskin AR; Kuffner T; Weedon H; Milliken ST; Tak PP; Smith MD; Breit SN, 2007, 'Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis - A potential marker of erosive joint destruction', Arthritis Care & Research, 56, pp. 753 - 764

Anandacoomarasamy A; Moore J; McGill N; Manolios N; Englert H, 2006, 'Resolution of skin fibrosis and joint contractures in aggressive diffuse systemic sclerosis using autologous stem cell transplantation', APLAR Journal of Rheumatology, 9, pp. 298 - 301, http://dx.doi.org/10.1111/j.1479-8077.2006.00218.x

Bryant A; Moore J, 2006, 'Rituximab and its potential for the treatment of rheumatoid arthritis', Therapeutics and Clinical Risk Management, 2, pp. 207 - 212, http://dx.doi.org/10.2147/tcrm.2006.2.2.207

Pierson RN; Moore J; Merion RM; Azimzadeh AMI, 2006, 'ABO-incompatible lung transplantation', International Congress Series, 1292, pp. 63 - 69, http://dx.doi.org/10.1016/j.ics.2006.03.052

Dodds AJ; Moore JJ; Goh K; Bradstock KF; Szer J; Nivison-Smith I; Ma DD, 2006, 'A matched pair retrospective comparison of adult unrelated and sibling donor allogeneic stem cell transplantation (SCT) for AML', Biology of Blood and Marrow Transplantation, 12, pp. 27 - 27

Bai L; Deng Y; Dodds AJ; Milliken ST; Moore JJ; Ma DD, 2006, 'A SYBR green-based real-time PCR method for detection of haemopoietic chimerism in allogenic haemopoietic stem cell transplant recipients', European Journal of Haematology, 77, pp. 425 - 431

Carlin S; Moore JJ; Zaunders J; Kelleher T; Ma DD, 2006, 'Generation in vitro of T lineage cells from human adult haematopoietic stem cells', Clinical Immunology, 119, pp. S160 - S160

Al-mashaleh M; Bak H; Moore JJ; Manolios N; Englert H, 2006, 'Resolution of sclerodermatous myocarditis after autologous stem cell transplantation', Annals of the Rheumatic Diseases, 65, pp. 1247 - 1248

Carlin S; Moore JJ; Zaunders J; Kelleher AD; Ma DD, 2006, 'T lineage differentiation in vitro of adult Haematopoietic Stem Cells', CYTOMETRY PART A, 69A, pp. 399 - 400

Bai L; Deng Y-M; Dodds AJ; Milliken S; Moore J; Ma DDF, 2005, 'A SYBR Green - Based Real Time PCR Method for Detection of Haemopoietic Chimerism in Allogeneic Stem Cell Transplant Recipients.', Blood, 106, pp. 5222 - 5222, http://dx.doi.org/10.1182/blood.v106.11.5222.5222

Johnston AJ; Dodds AJ; Ma DD; Milliken ST; Fay KC; Cunningham PH; Moore JJ, 2005, 'Cytomegalovirus Viraemia after Allogeneic Transplant: A Prospective Study of a Risk-Adapted Strategy in a Single Transplant Unit.', Blood, 106, pp. 5374 - 5374, http://dx.doi.org/10.1182/blood.v106.11.5374.5374

Ma DDF; Kovacic JC; Dodds A; Tao H; McDonald P; Feneley MP; Muller DW; Fruend J; Milliken S; Moore J; Itescu S; Graham RM, 2005, 'Granulocyte-Colony Stimulating Factor Decreases Angina and Improves Exercise Capacity in Patients with Chronic Refractory ‘No Option’ Ischemic Heart Disease.', Blood, 106, pp. 4215 - 4215, http://dx.doi.org/10.1182/blood.v106.11.4215.4215

Englert H; Katelaris C; McGill N; Schrieber L; Moore JJ, 2005, '`Grape-sultana` sign represents a favourable response to aggressive treatment of early diffuse systemic scleroderma', Internal Medicine Journal, 35, pp. 436 - 437

Bai L; Deng YM; Dodds AJ; Milliken ST; Moore JJ; Ma DD, 2005, 'A SYBR green-based real time PCR method for detection of haemopoietic chimerism in allogeneic stem cell transplant recipients', Blood, 106, pp. 389B - 389B

Gratwohl A; Passweg J; Bocelli-Tyndall C; Fassas A; Van Laar J; Farge D; Andolina M; Arnold RH; Carreras E; Finke J; Kotter I; Kozak T; Lisukov I; Lowenberg B; Marmont A; Moore JJ; Saccardi R; Snowden J; van den Hoogen F; Wulffraat N; Zhou X; Tyndall A, 2005, 'Autologous hematopoietic stem cell transplantation for autoimmune diseases', Bone Marrow Transplantation, 35, pp. 869 - 879

Dodds AJ; Ma DD; Milliken ST; Fay K; Cunningham PH; Moore JJ, 2005, 'Cytomegalovirus viraemia after allogeneic transplant: A prospective study of a risk-adapted strategy in a single transplant unit', Blood, 106, pp. 429B - 429B

Ma DD; Kovacic JC; Dodds AJ; Tao H; Mcdonald PS; Feneley MP; Muller DW; Fruend J; Milliken ST; Moore JJ; Itescu S; Graham RM, 2005, 'Granulocyte-colony stimulating factor decreases angina and improves exercise capacity in patients with chronic refractory `no option` ischemic heart disease', Blood, 106, pp. 134B - 134B

Ponchel F; Verburg R; Bingham SJ; Brown AK; Moore JJ; Protheroe A; Short K; Lawson C; Morgan AW; Quinn M; Buch M; Field SL; Maltby SL; Masurel A; Douglas SH; Straszynski L; Fearon U; Veale DJ; Patel P; McGonagle D; Snowden J; Markham AF; Ma DD; Van Laar J; Papadaki HA; Emery P; Isaacs JD, 2005, 'Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia', Arthritis Research and Therapy, 7, pp. 80 - 92

David S; Englert H; Furlong TM; Rainer SP; Moore JJ, 2005, 'Red cell fragmentation preceding a renal crisis in a patient with systemic sclerosis undergoing haematopoietic stem cell transplantation', Bone Marrow Transplantation, 35, pp. 629 - 630

Zaunders JJ; Dyer WB; Wang B; Munier ML; Miranda-Saksena M; Newton R; Moore J; Mackay CR; Cooper DA; Saksena NK; Kelleher AD, 2004, 'Identification of circulating antigen-specific CD4⁺ T lymphocytes with a CCR5⁺, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection', Blood, 103, pp. 2238 - 2247, http://dx.doi.org/10.1182/blood-2003-08-2765

Moore JJ; Bradstock K; Dodds AJ; Szer J; Smith I; Goh KE; Ma DD, 2004, 'A matched pair retrospective comparison of adult unrelated and sibling donor allogeneic transplantation for AML', Blood, 104, pp. 378B - 378B

Back to profile page